To test the functional relevance of endogenous Solo in the regulation of Src and cell motility in cancer cells, we first analyzed Solo expression in a panel of triple negative breast cancer (TNBC) cells, which often exhibit high levels of EMT TFs as well as SFKs.23 The gene discussed is ARHGEF40; the disease is triple-negative breast carcinoma.